PBPK modeling of complex hydrocarbon mixtures: Gasoline

Environmental Toxicology and Pharmacology

Volumn 16, Issue 1-2, 2004, Pages 107-119

  Dennison, James E ^a   Andersen, Melvin E ^b   Dobrev, Ivan D ^c   Mumtaz, Moiz M ^d   Yang, Raymond S H ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^c ENVIRON INTERNATIONAL CORPORATION   (United States)

^d AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

Author keywords

Benzene; BTEX; Complex mixtures; Ethylbenzene; Gasoline; Hexane; PBPK; PBTK; Pharmacokinetic; Toluene; Xylene

Indexed keywords

BENZENE; ETHYLBENZENE; GASOLINE; HEXANE; HYDROCARBON; ORTHO XYLENE; TOLUENE;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GAS TRANSPORT; MALE; MODEL; NONHUMAN; PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL; PRIORITY JOURNAL; RAT; TOXICOKINETICS;

EID: 1542316259     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2003.10.003     Document Type: Article

References (47)

1. ACGIH, 2003. 2003 TLVs and BEIs: Threshold Limit Values for Chemical Substances and Physical Agents; Biological Exposure Indices. American Conference of Governmental Industrial Hygienists, Cincinnati.
2. Agrawal A.K., Goel S.K., Seth P.K., Pandya K.P. Central nervous system effect of 2,5-hexane diol. Neurotoxicology. 6(3):1985;53-59.
3. Andersen, M.E., Clewell, H.J., 1984. Pharmacokinetic interactions of mixtures. In: Proceedings of the 14th Conference on Environmental Toxicology. November 1983, Dayton, OH, Paper No. 16.
4. Andersen M.E., Gargas M.L., Clewell H.J.D., Severyn K.M. Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene in vivo using gas uptake methods. Toxicol. Appl. Pharmacol. 89(2):1987;149-157.
5. Bond J.A., Leavens T.L., Seaton M.J., Medinsky M.A. Predicting the toxicity of chemical mixtures based on knowledge of individual components. CIIT Activities. 17(12):1997;1-7.
6. Borghoff S.J., Murphy J.E., Medinsky M.A. Development of physiologically based pharmacokinetic model for methyl tertiary-butyl ether and tertiary-butanol in male Fisher-344 rats. Fundam. Appl. Toxicol. 30(2):1996;264-275.
7. Brown R.P., Delp M.D., Lindstedt S.L., Rhomberg L.R., Beliles R.P. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health. 13(4):1997;407-484.
8. Cole C.E., Tran H.T., Schlosser P.M. Physiologically based pharmacokinetic modeling of benzene metabolism in mice through extrapolation from in vitro to in vivo. J. Toxicol. Environ. Health A. 62(6):2001;439-465.
9. Dement J.M., Hensley L., Gitelman A. Carcinogenicity of gasoline: a review of epidemiological evidence. Ann. N. Y. Acad. Sci. 837:1997;53-76.
10. Dennison J.E., Andersen M.E., Yang R.S.H. Characterization of the pharmacokinetics of gasoline using PBPK modeling with a complex mixtures chemical lumping approach. Inhal. Toxicol. 15(10):2003;961-986.
11. Dobrev I.D., Andersen M.E., Yang R.S. In silico toxicology: simulating interaction thresholds for human exposure to mixtures of trichloroethylene, tetrachloroethylene, and 1,1,1-trichloroethane. Environ. Health Perspect. 110(10):2002;1031-1039.
12. Economides, 2002. Testimony of Nicholas Economides to US House of Representatives, April 23, 2002. US House of Representatives, http://reform.house.gov/reg/hearings/testimony/042302economides.htm.
13. Filser, J.G., Johanson, G., Kessler, W., Kreuzer, P.E., Stei, P., Baur, C., Csanady, G.A., 1993. A pharmacokinetic model to describe toxicokinetic interactions between 1,3-butadiene and styrene in rats: predictions for human exposure, IARC Scientific Publications (Lyon)(Report #127), p. 65-78.
14. Gargas M.L., Andersen M.E., Clewell H.J.D. A physiologically based simulation approach for determining metabolic constants from gas uptake data. Toxicol. Appl. Pharmacol. 86(3):1986;341-352.
15. Gargas M.L., Burgess R.J., Voisard D.E., Cason G.H., Andersen M.E. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 98(1):1989;87-99.
16. Graham D.G., Amarnath V., Valentine W.M., Pyle S.J., Anthony D.C. Pathogenetic studies of hexane and carbon disulfide neurotoxicity. Crit. Rev. Toxicol. 25(2):1995;91-112.
17. Haddad S., Tardif R., Charest-Tardif G., Krishnan K. Physiological modeling of the toxicokinetic interactions in a quaternary mixture of aromatic hydrocarbons. Toxicol. Appl. Pharmacol. 161(3):1999;249-257.
18. Hakkola M., Honkasalo M.L., Pulkkinen P. Neuropsychological symptoms among tanker drivers exposed to gasoline. Occup. Med. (Lond.). 46(2):1996;125-130.
19. Hilderbrand R.L., Andersen M.E. In vivo kinetic constants for the metabolism of inhaled hydrocarbon toxicants as determined by gas uptake methods. Toxicologist. 1:1981;86-87.
20. INEGI, 2002. Gasoline Production Volume, by Selected Countries, 1995-1999. National Institute of Statistics, Geography and Informatics (INEGI), http://www.inegi.gob.mx/estadistica/ingles/economia/internacional/ine_10.html.
21. Jex T.T., Wyman D.O. A minireview of benzene. Toxic. Substance Mechanisms. 15(2):1996;135-143.
22. Jia X., Xiao P., Jin X., Shen G., Wang X., Jin T., Nordberg G. Adverse effects of gasoline on the skin of exposed workers. Contact Dermatitis. 46(1):2002;44-47.
23. Johanson G., Filser J.G. Experimental data from closed chamber gas uptake studies in rodents suggest lower uptake rate of chemical than calculated from literature values on alveolar ventilation. Arch. Toxicol. 66(4):1992;291-295.
24. Kenyon E.M., Kraichely R.E., Hudson K.T., Medinsky M.A. Differences in rates of benzene metabolism correlate with observed genotoxicity. Toxicol. Appl. Pharmacol. 136(1):1996;49-56.
25. Korsak Z., Swiercz R., Jedrychowski R. Effects of acute combined exposure to N-butyl alcohol and M-xylene. Pol. J. Occup. Med. Environ. Health. 6(1):1993;35-41.
26. Krishnan K., Clewell H.J., Andersen M.E. Physiologically-based pharmacokinetic analyses of simple mixtures. Environ. Health Perspect. 102:1994;151-155.
27. Laitinen J., Kangas J., Pekari K., Liesivuori J. Short-time exposure to benzene and gasoline at garages. Chemosphere. 28(1):1994;197-205.
28. Macey, R.I., Oster, G.F., 2002. Berkeley Madonna. University of California, Berkeley, CA. Available: http://www.berkeleymadonna.com/ [accessed 20 Sept 2002].
29. Medinsky M.A., Sabourin P.J., Lucier G., Birnbaum L.S., Henderson R.F. A physiological model for simulation of benzene metabolism by rats and mice. Toxicol. Appl. Pharmacol. 99(2):1989;193-206.
30. Medinsky, M.A., 1997. Predicting the toxicity of gasoline vapors based on knowledge of fuel components, Abstr. Pap. Am. Chem. Soc. Vol. 214, 35-FUEL.
31. Muller J., Greff G. Research on the relationships between toxicity of chemicals of industrial interest and physico-chemical properties: irritation test of the upper respiratory tract applied to four chemical families. Food Chem. Toxicol. 22(8):1984;661-664.
32. OEHHA, 1997a. Public health goal for ethylbenzene. In: Drinking Water. Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, Pesticide and Environmental Toxicology Section, Sacramento, CA.
33. OEHHA, 1997b. Public health goal for xylene. In: Drinking Water. Pesticide and Environmental Toxicology Section, Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, Sacramento, CA.
34. OEHHA, 1999. Public Health Goal for Toluene In Drinking Water. Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, Pesticide and Environmental Toxicology Section Sacramento, CA.
35. Perbellini L., Mozzo P., Brugnone F., Zedde A. Physiologicomathematical model for studying human exposure to organic solvents: kinetics of blood/tissue n-hexane concentrations and of 2,5- hexanedione in urine. Br. J. Ind. Med. 43(11):1986;760-768.
36. Pierce C.H., Dills R.L., Morgan M.S., Nothstein G.L., Shen D.D., Kalman D.A. Interindividual differences in 2H8-toluene toxicokinetics assessed by semiempirical physiologically based model. Toxicol. Appl. Pharmacol. 139(1):1996;49-61.
37. Purcell K.J., Cason G.H., Gargas M.L., Andersen M.E., Travis C.C. In vivo metabolic interactions of benzene and toluene. Toxicol. Lett. 52(2):1990;141-152.
38. Ramsey J.C., Andersen M.E. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol. 73(1):1984;159-175.
39. Rao H.V., Ginsberg G.L. A physiologically-based pharmacokinetic model assessment of methyl t-butyl ether in groundwater for a bathing and showering determination. Risk Anal. 17(5):1997;583-598.
40. Tardif R., Charest-Tardif G., Brodeur J., Krishnan K. Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans. Toxicol. Appl. Pharmacol. 144(1):1997;120-134.
41. Thrall K.D., Poet T.S. Determination of biokinetic interactions in chemical mixtures using real-time breath analysis and physiologically based pharmacokinetic modeling. J. Toxicol. Environ. Health A. 59(8):2000;653-670.
42. Thrall K.D., Callahan P.J., Weitz K.K., Edwards J.A., Brinkman M.C., Kenny D.V. Design and evaluation of a breath-analysis system for biological monitoring of volatile compound. AIHAJ. 62(1):2001;28-35.
43. Travis C.C., Quillen J.L., Arms A.D. Pharmacokinetics of benzene. Toxicol. Appl. Pharmacol. 102(3):1990;400-420.
44. Travis C.C., Fox M.T., Simmons W.M., Lyon B.F. Co-exposure to gasoline vapor decreases benzene metabolism in Fischer- 344 rats. Toxicol. Lett. 62(2-3):1992;231-240.
45. Verhaar H.J., Morroni J.R., Reardon K.F., Hays S.M., Gaver D.P. Jr., Carpenter R.L., Yang R.S. A proposed approach to study the toxicology of complex mixtures of petroleum products: the integrated use of QSAR, lumping analysis and PBPK/PD modeling. Environ. Health Perspect. 105(Suppl. 1):1997;179-195.
46. Wixtrom R.N., Brown S.L. Individual and population exposures to gasoline. J. Expo. Anal. Environ. Epidemiol. 2(1):1992;23-78.
47. Yu X.Z., Johanson G., Ichihara G., Shibata E., Kamijima M., Ono Y., Takeuchi Y. Physiologically based pharmacokinetic modeling of metabolic interactions between n-hexane and toluene in humans. J. Occup. Health. 40(4):1998;293-301.